Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 192.68 Million CNY | 2.92% |
| 2022 | 187.21 Million CNY | -58.91% |
| 2021 | 455.57 Million CNY | 203.23% |
| 2020 | -441.32 Million CNY | -892.11% |
| 2019 | 55.71 Million CNY | 154.66% |
| 2018 | 21.87 Million CNY | -58.54% |
| 2017 | 52.76 Million CNY | 85.62% |
| 2016 | 28.42 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 8.36 Million USD | 0.0% |
| 2024 Q1 | 8.41 Million USD | -10.25% |
| 2023 FY | 192.68 Million CNY | 2.92% |
| 2023 Q1 | 9.09 Million USD | -61.68% |
| 2023 Q2 | 18.01 Million USD | 98.17% |
| 2023 Q3 | 4.64 Million USD | -74.23% |
| 2023 Q4 | 9.37 Million USD | 101.97% |
| 2022 FY | 187.21 Million CNY | -58.91% |
| 2022 Q4 | 23.72 Million USD | 104.39% |
| 2022 Q3 | 11.6 Million USD | -25.12% |
| 2022 Q2 | 15.5 Million USD | 0.0% |
| 2021 Q4 | 14.44 Million USD | 0.0% |
| 2021 FY | 455.57 Million CNY | 203.23% |
| 2021 Q2 | 22.21 Million USD | 0.0% |
| 2020 Q2 | 5.46 Million USD | 0.0% |
| 2020 Q4 | 10.94 Million USD | 0.0% |
| 2020 FY | -441.32 Million CNY | -892.11% |
| 2019 Q2 | 4.55 Million USD | 0.0% |
| 2019 Q4 | 3.36 Million USD | 0.0% |
| 2019 FY | 55.71 Million CNY | 154.66% |
| 2018 FY | 21.87 Million CNY | -58.54% |
| 2017 FY | 52.76 Million CNY | 85.62% |
| 2016 FY | 28.42 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bioxytran, Inc. | -3.82 Million USD | 5143.863% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 368.413% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 73720.122% |
| SQZ Biotechnologies Company | -75.82 Million USD | 354.115% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 6859.605% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 1179.638% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | -135.404% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 12644.066% |
| Marizyme, Inc. | -34.08 Million USD | 665.276% |
| Genus plc | 6.4 Million USD | -2910.672% |
| Pharming Group N.V. | -4.87 Million USD | 4048.791% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 9799.725% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 20787.904% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 2407.581% |
| ContraFect Corporation | -56.88 Million USD | 438.7% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 13843.526% |
| IMV Inc. | -38.67 Million USD | 598.256% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 7104.518% |
| ONE Bio Corp. | 13.68 Million USD | -1308.342% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 426.637% |
| Mesoblast Limited | -84.14 Million USD | 328.984% |
| MultiCell Technologies, Inc. | -722.81 USD | 26657589.52% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | -5343.023% |
| Genscript Biotech Corporation | -415.79 Million USD | 146.341% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 49560.431% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 7433.259% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -3820.456% |
| Biomind Labs Inc. | -1 Million USD | 19185.026% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 6741.379% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 2998.354% |
| Skye Bioscience, Inc. | -13.67 Million USD | 1509.346% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 10435.019% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | -1877.766% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 643405.956% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 4330.397% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 3919.678% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 1314.154% |
| Accustem Sciences Inc. | -3.74 Million USD | 5243.125% |
| EV Biologics, Inc. | -483.06 Thousand USD | 39987.84% |
| Q BioMed Inc. | -3.44 Million USD | 5692.121% |
| GB Sciences, Inc. | -1.42 Million USD | 13664.363% |
| Alpha Cognition Inc. | -9.7 Million USD | 2085.276% |
| CSL Limited | 3.7 Billion USD | 94.795% |
| Agentix Corp. | -1.37 Million USD | 14146.448% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 450.509% |
| Enzolytics Inc. | -2.14 Million USD | 9067.005% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | -12.74 Million USD | 1611.358% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 6181.639% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 10070.092% |
| argenx SE | -425.04 Million USD | 145.332% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 447.127% |
| HST Global, Inc. | -140.9 Thousand USD | 136844.803% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 18556.226% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 17228.809% |
| Halberd Corporation | -75.05 Thousand USD | 256839.507% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 6699.99% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 5758.86% |
| Zenith Capital Corp. | -8.94 Million USD | 2254.568% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 12300.107% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 7947.581% |
| AVAX Technologies, Inc. | 6.69 Million USD | -2778.925% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 112445.354% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 9711.29% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 1106138.689% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | 7911.177% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 19680.551% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 15441.003% |
| Kadimastem Ltd | -3.04 Million USD | 6437.735% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 2576.973% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 106270.207% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 14528.525% |
| LadRx Corporation | -3.82 Million USD | 5139.274% |
| Cell Source, Inc. | -4.32 Million USD | 4554.742% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 46476.11% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 28149.057% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 28149.057% |
| Affymax, Inc. | -15.04 Million USD | 1380.626% |
| Mobile Lads Corp. | -554.55 Thousand USD | 34845.83% |
| Itoco Inc. | -919.14 Thousand USD | 21063.401% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 4646.111% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 17319.214% |
| International Stem Cell Corporation | -663 Thousand USD | 29162.293% |
| CytoDyn Inc. | -18.05 Million USD | 1167.023% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 765626.42% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 87652.141% |
| Qrons Inc. | -643.67 Thousand USD | 30034.734% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 34219.914% |
| SYBLEU INC | -149.18 Thousand USD | 129261.416% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | 8740.962% |
| Rebus Holdings, Inc. | -664 Thousand USD | 29118.524% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 10708.428% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 366139.134% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 947410.718% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 631.305% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 12008.714% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 26285.626% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 6293.603% |
| Neutra Corp. | -229.48 Thousand USD | 84062.856% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 1198.597% |
| PureTech Health plc | -146.19 Million USD | 231.795% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 996.57% |
| IXICO plc | -1.43 Million USD | 13508.699% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 2130.165% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 258.188% |
| CSL Limited | 3.81 Billion USD | 94.945% |
| Cellectis S.A. | -108.85 Million USD | 277.005% |